• Home
  • Practice Focus
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
    • How I Do It
    • TRIO Best Practices
  • Business of Medicine
    • Health Policy
    • Legal Matters
    • Practice Management
    • Tech Talk
    • AI
  • Literature Reviews
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Career
    • Medical Education
    • Professional Development
    • Resident Focus
  • ENT Perspectives
    • ENT Expressions
    • Everyday Ethics
    • From TRIO
    • The Great Debate
    • Letter From the Editor
    • Rx: Wellness
    • The Voice
    • Viewpoint
  • TRIO Resources
    • Triological Society
    • The Laryngoscope
    • Laryngoscope Investigative Otolaryngology
    • TRIO Combined Sections Meetings
    • COSM
    • Related Otolaryngology Events
  • Search

The Latest on Olfactory Dysfunction and COVID-19

by Renée Bacher • August 17, 2021

  • Tweet
  • Email
Print-Friendly Version

Jennifer VillwockOlfactory dysfunction can be from viral-induced olfactory nerve damage, local inflammation and damage to the supporting cells and sinonasal epithelium, or both. —Jennifer Villwock, MD

You Might Also Like

  • Parosmia Associated with Functional Recovery from Post-Infectious Olfactory Dysfunction
  • Parosmia Is Distinct from Quantitative Olfactory Loss in Patients with COVID-19–Related Dysfunction
  • Persistent Olfactory Dysfunction Caused by COVID-19 Affects Nearly One-Third of Patient Cohort
  • COVID-19–Related Olfactory Dysfunction Associated with Major Depressive Disorder Likelihood
Explore This Issue
August 2021

Parosmia and Phantosmia

For those who do recover their sense of smell, the recovery isn’t always easy and can often be accompanied by parosmia and/or phantosmia. Both conditions have gained a lot of attention in connection with COVID-19, according to Bradley J. Goldstein, MD, PhD, an associate professor in the departments of head and neck surgery and communication sciences and of neurobiology at Duke University School of Medicine in Durham, N.C.

“In a recent European study, parosmia was present in 28% to 59% of COVID-19 patients who had olfactory loss,” Dr. Goldstein said. While not everyone with smell loss will also develop parosmia, Dr. Goldstein added that it isn’t well understood why parosmia is so prominent in post-COVID-19 subjects and what exactly is causing it.

In COVID-19 and non-COVID-19 cases alike, parosmia and phantosmia often occur months after the initial illness or injury, Dr. Holbrook said. Phantosmia can occur during recovery from smell loss related to traumatic brain injury, for example, or can also be caused by seizures or migraines.

“As the regenerating nerves are finally making their way to connect into the olfactory bulb, which is the first brain structure that the nerves in the nose connect with, those nerves are not targeting back to the same spot that they did before,” Dr. Holbrook said. “So, the wiring is a little altered, and that alteration gives the experience of distorted smell.”

The distortion, unfortunately, does not lean toward scents like baking bread or fragrant roses. Common descriptors liken it to cigarette smoke, mold, rot, vomit, and sewage. And odors that may have previously smelled good to the patient, like coffee or their significant other, can trigger a really bad smell, which may cause a great deal more anxiety than smell loss alone. “For the patient, this isn’t promising, but since it can be a sign of recovery, a lot of us consider it a good thing,” said Dr. Holbrook.

Eric Holbrook, MDFor the patient, scent distortion isn’t promising, but since it can be a sign of recovery, a lot of us consider it a good thing. —Eric Holbrook, MD

Parosmia and phantosmia generally aren’t as well studied as anosmia or hyposmia, a loss of or a decreased sense of smell. This is also true in the setting of COVID-19. In Dr. Villwock’s practice, the majority of her patients who have survived COVID-19 will express some degree of parosmia and/or phantosmia and commonly describe it as “wet dog,” “moldy cigarette,” or some other “weird, bad smell.” It often seems unprovoked but can be triggered by exposure to an odorant, she said, and some have it constantly, while for others it’s intermittent. 

“In my practice, patients are more likely to have these issues if they have some residual olfactory function,” Dr. Villwock said. “Prior to COVID-19, this was a phenomenon I was frequently seeing in my patients with persistent olfactory dysfunction from other viruses. Parosmia and/or phantosmia most commonly occurred during the first 12 months following the virus onset and usually lasted a few months before resolving itself.”

If patients visited her within that first year of smell loss, she would always counsel them about the possibility of developing parosmia and phantosmia. While she didn’t have a way to predict who would get it, she wanted them to be aware of the conditions so that they would not panic if either one developed.

Dr. Yan said that in her experience, parosmia typically occurs two to three months after COVID-19 patients have experienced their initial smell loss or had a COVID-19 diagnosis, and it seems to be more common in female patients. “Many people will say that they feel as though they’ve recovered somewhat in terms of their sense of smell,” she said, “and then a very sudden, abrupt light switch goes on and they realize their sense of smell has become completely distorted,” Dr. Yan said.

Pages: 1 2 3 4 5 | Single Page

Filed Under: Features, Home Slider, Rhinology Tagged With: clincal research, COVID19, smell loss, treatmentIssue: August 2021

You Might Also Like:

  • Parosmia Associated with Functional Recovery from Post-Infectious Olfactory Dysfunction
  • Parosmia Is Distinct from Quantitative Olfactory Loss in Patients with COVID-19–Related Dysfunction
  • Persistent Olfactory Dysfunction Caused by COVID-19 Affects Nearly One-Third of Patient Cohort
  • COVID-19–Related Olfactory Dysfunction Associated with Major Depressive Disorder Likelihood

The Triological SocietyENTtoday is a publication of The Triological Society.

Polls

Have you invented or patented something that betters the field of otolaryngology?

View Results

Loading ... Loading ...
  • Polls Archive

Top Articles for Residents

  • Applications Open for Resident Members of ENTtoday Edit Board
  • How To Provide Helpful Feedback To Residents
  • Call for Resident Bowl Questions
  • New Standardized Otolaryngology Curriculum Launching July 1 Should Be Valuable Resource For Physicians Around The World
  • Do Training Programs Give Otolaryngology Residents the Necessary Tools to Do Productive Research?
  • Popular this Week
  • Most Popular
  • Most Recent
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment

    • The Road Less Traveled—at Least by Otolaryngologists

    • The Best Site for Pediatric TT Placement: OR or Office?

    • Rating Laryngopharyngeal Reflux Severity: How Do Two Common Instruments Compare?

    • Otolaryngologists Are Still Debating the Effectiveness of Tongue Tie Treatment

    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment

    • Rating Laryngopharyngeal Reflux Severity: How Do Two Common Instruments Compare?

    • Is Middle Ear Pressure Affected by Continuous Positive Airway Pressure Use?

    • Otolaryngologists Are Still Debating the Effectiveness of Tongue Tie Treatment

    • Complications for When Physicians Change a Maiden Name

    • Leaky Pipes—Time to Focus on Our Foundations
    • You Are Among Friends: The Value Of Being In A Group
    • How To: Full Endoscopic Procedures of Total Parotidectomy
    • How To: Does Intralesional Steroid Injection Effectively Mitigate Vocal Fold Scarring in a Rabbit Model?
    • What Is the Optimal Anticoagulation in HGNS Surgery in Patients with High-Risk Cardiac Comorbidities?

Follow Us

  • Contact Us
  • About Us
  • Advertise
  • The Triological Society
  • The Laryngoscope
  • Laryngoscope Investigative Otolaryngology
  • Privacy Policy
  • Terms of Use
  • Cookies

Wiley

Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1559-4939